Christopher Pasquale
Stock Analyst at Barclays
(4.28)
# 1,413
Out of 5,088 analysts
170
Total ratings
61.3%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Christopher Pasquale
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Maintained: Sell | $20 | $23.50 | -14.89% | 6 | Oct 30, 2026 | |
| SYK Stryker | Maintained: Buy | $375 → $365 | $311.75 | +17.08% | 15 | Oct 30, 2026 | |
| DXCM DexCom | Maintained: Buy | $115 → $120 | $79.93 | +50.13% | 13 | Oct 30, 2026 | |
| AXGN Axogen | Reiterated: Buy | $50 → $60 | $49.63 | +20.89% | 6 | Oct 29, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $30 | $17.58 | +70.65% | 2 | Oct 29, 2026 | |
| BSX Boston Scientific | Reiterated: Hold | $48 | $42.69 | +12.44% | 17 | Oct 29, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $85 → $95 | $76.42 | +24.31% | 3 | Oct 29, 2026 | |
| COO The Cooper Companies | Reiterated: Hold | $60 | $60.34 | -0.56% | 8 | Oct 28, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $120 | $104.57 | +14.76% | 14 | Oct 22, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $485 → $500 | $448.76 | +11.42% | 2 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $17 → $10 | $6.42 | +55.76% | 2 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $204 → $165 | $198.34 | -16.81% | 3 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $20.40 | +17.65% | 1 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $90 → $110 | $94.44 | +16.48% | 9 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 → $0.5 | $0.4698 | +6.43% | 2 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $105 | $81.25 | +29.23% | 1 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $198 → $150 | $152.50 | -1.64% | 9 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $10 | $9.75 | +2.56% | 5 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $18 | $19.79 | -9.04% | 6 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $145 → $100 | $97.47 | +2.60% | 12 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | CHF 57.94 | CHF 58.76 | -1.40% | 3 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $65 | $71.18 | -8.68% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $120 → $95 | $97.11 | -2.17% | 5 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $19.25 | +14.29% | 1 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $30 | $20.30 | +47.78% | 5 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $67.12 | +78.78% | 1 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $305 | $321.97 | n/a | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 4 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $37.28 | n/a | 1 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $85 | $24.31 | n/a | 4 | Nov 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $80 | $12.83 | n/a | 1 | Jul 31, 2015 |
Baxter International
Oct 30, 2026
Maintained: Sell
Price Target: $20
Current: $23.50
Upside: -14.89%
Stryker
Oct 30, 2026
Maintained: Buy
Price Target: $375 → $365
Current: $311.75
Upside: +17.08%
DexCom
Oct 30, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $79.93
Upside: +50.13%
Axogen
Oct 29, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $49.63
Upside: +20.89%
Beta Bionics
Oct 29, 2026
Reiterated: Buy
Price Target: $30
Current: $17.58
Upside: +70.65%
Boston Scientific
Oct 29, 2026
Reiterated: Hold
Price Target: $48
Current: $42.69
Upside: +12.44%
GE HealthCare Technologies
Oct 29, 2026
Reiterated: Buy
Price Target: $85 → $95
Current: $76.42
Upside: +24.31%
The Cooper Companies
Oct 28, 2026
Reiterated: Hold
Price Target: $60
Current: $60.34
Upside: -0.56%
Abbott Laboratories
Oct 22, 2026
Reiterated: Buy
Price Target: $120
Current: $104.57
Upside: +14.76%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $485 → $500
Current: $448.76
Upside: +11.42%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $17 → $10
Current: $6.42
Upside: +55.76%
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $204 → $165
Current: $198.34
Upside: -16.81%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $20.40
Upside: +17.65%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $90 → $110
Current: $94.44
Upside: +16.48%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $3.5 → $0.5
Current: $0.4698
Upside: +6.43%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $105
Current: $81.25
Upside: +29.23%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $198 → $150
Current: $152.50
Upside: -1.64%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $30 → $10
Current: $9.75
Upside: +2.56%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $14 → $18
Current: $19.79
Upside: -9.04%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $145 → $100
Current: $97.47
Upside: +2.60%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: CHF 57.94
Current: CHF 58.76
Upside: -1.40%
Oct 6, 2026
Initiated Coverage: Sell
Price Target: $65
Current: $71.18
Upside: -8.68%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $120 → $95
Current: $97.11
Upside: -2.17%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $22
Current: $19.25
Upside: +14.29%
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $50 → $30
Current: $20.30
Upside: +47.78%
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $120
Current: $67.12
Upside: +78.78%
Jul 30, 2025
Upgraded: Buy
Price Target: $305
Current: $321.97
Upside: n/a
May 7, 2021
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 6, 2019
Reiterated: Buy
Price Target: $150
Current: $37.28
Upside: n/a
Nov 5, 2018
Reiterated: Buy
Price Target: $57 → $85
Current: $24.31
Upside: n/a
Jul 31, 2015
Upgraded: Buy
Price Target: $80
Current: $12.83
Upside: n/a